Cellular adhesion to the extracellular matrix involves members of the integrin family of cell adhesion receptors. Recent evidence indicates that integrins not only serve as receptors for cell adhesion but also directly transduce signals that regulate cellular proliferation, differentiation, gene expression, cell morphology and migration. Therefore the goals of this proposal will address the structural basis of integrin-ligand recognition as it relates to signal transduction events, integrin- cytoskeletal association and the resulting effects on cellular morphology and migration. This proposal will focus on the post-ligand binding events promoted by two homologous integrins, avbeta3 and avbeta5 that share the ability to bind vitronectin. We will take advantage of our recent findings that while both aV-containing integrins contribute to cell attachments to vitronectin only avbeta3 localizes to focal contacts. Based on these findings and the primary sequence comparison of beta3 and beta5 it is apparent that the structurally unrelated cytoplasmic tails of these proteins may be responsible for distinct signal transduction events and differential association with the actin-cytoskeleton. This proposal will focus on four related goals. First, we will characterize the molecular events involved in the binding of vitronectin by avbeta3 based on our recent evidence that this occurs in two steps: 1) RGD recognition, 2) followed by a molecular stabilization of this interaction that appears to be RGD-independent. This will include an examination of the regions in the ligand vitronectin to which av integrins bind using vitronectin fusion proteins, peptide, and anti-vitronectin monoclonal antibodies that block cell adhesion. Secondly, we will determine why integrin avbeta3 and avbeta5 differ in their ability to associate with the actin cytoskeleton. We will focus on the cytoplasmic tails of beta3 and beta5 in these studies. Specifically, mutant and chimeric integrins (beta3/beta5) with altered cytoplasmic tails will be transiently and/or stably expressed to allow us to investigate the role of the integrin beta subunit cytoplasmic domain in this process. A third goal of the proposed studies will be to examine the ability of integrins avbeta3 and avbeta5 to transmit early signals and whether the structural difference in these integrins leads to distinct cell signals. Initially we will measure the ability of these receptors to regulate the Na-H antiporter, intracellular calcium, inositol lipid synthesis and tyrosine phosphorylation. Finally, we will determine the role of these integrins in the post-ligand binding events of cell spreading, migration and proliferation. The objectives of this proposal are therefore designed to gain an understanding at the molecular level of how integrin occupancy mediates cellular responses to the extracellular matrix and whether these events facilitate the progression or metastasis of human tumor cells.
| Seguin, Laetitia; Camargo, Maria F; Wettersten, Hiromi I et al. (2017) Galectin-3, a Druggable Vulnerability for KRAS-Addicted Cancers. Cancer Discov 7:1464-1479 |
| Cosset, Érika; Ilmjärv, Sten; Dutoit, Valérie et al. (2017) Glut3 Addiction Is a Druggable Vulnerability for a Molecularly Defined Subpopulation of Glioblastoma. Cancer Cell 32:856-868.e5 |
| Seguin, Laetitia; Desgrosellier, Jay S; Weis, Sara M et al. (2015) Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance. Trends Cell Biol 25:234-40 |
| Franovic, Aleksandra; Elliott, Kathryn C; Seguin, Laetitia et al. (2015) Glioblastomas require integrin ?v?3/PAK4 signaling to escape senescence. Cancer Res 75:4466-73 |
| Seguin, Laetitia; Kato, Shumei; Franovic, Aleksandra et al. (2014) An integrin ??-KRAS-RalB complex drives tumour stemness and resistance to EGFR inhibition. Nat Cell Biol 16:457-68 |
| Cheresh, David A; Stupack, Dwayne G (2014) Tumor angiogenesis: putting a value on plastic GEMMs. Circ Res 114:9-11 |
| Seguin, Laetitia; Gozo, Maricel; Weis, Sara M et al. (2014) Targeting the Achilles' heel of drug-resistant cancer stem cells. Cell Cycle 13:2017-8 |
| Desgrosellier, Jay S; Lesperance, Jacqueline; Seguin, Laetitia et al. (2014) Integrin ?v?3 drives slug activation and stemness in the pregnant and neoplastic mammary gland. Dev Cell 30:295-308 |
| Lau, Steven K M; Shields, David J; Murphy, Eric A et al. (2012) EGFR-mediated carcinoma cell metastasis mediated by integrin ?v?5 depends on activation of c-Src and cleavage of MUC1. PLoS One 7:e36753 |
| Huang, M; Anand, S; Murphy, E A et al. (2012) EGFR-dependent pancreatic carcinoma cell metastasis through Rap1 activation. Oncogene 31:2783-93 |
Showing the most recent 10 out of 96 publications
